AG
MGNX icon

Advisor Group’s MacroGenics MGNX Stock Holding History

Advisor Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$34K Buy
3,137
+688
+28% +$6.81K ﹤0.01% 3664
2019
Q3 		$31K Buy
2,449
+397
+19% +$5.72K ﹤0.01% 3706
2019
Q2 		$35K Buy
2,052
+107
+6% +$1.84K ﹤0.01% 3607
2019
Q1 		$35K Buy
1,945
+175
+10% +$3.02K ﹤0.01% 3629
2018
Q4 		$22K Buy
1,770
+300
+20% +$5.03K ﹤0.01% 3743
2018
Q3 		$32K Buy
1,470
+500
+52% +$10.7K ﹤0.01% 3589
2018
Q2 		$20K Buy
+970
New +$21.8K ﹤0.01% 3715
2017
Q1 		– Sell
-47
Closed -$1K – 4752
2016
Q4 		$1K Hold
47
– – ﹤0.01% 4369
2016
Q3 		$1K Hold
47
– – ﹤0.01% 4318
2016
Q2 		$1K Buy
+47
New +$1.06K ﹤0.01% 4247

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advisor Group's MGNX Position: Q4 2019 in Review

Advisor Group increased its MacroGenics (MGNX) stake by 28% in Q4 2019, buying an estimated $6.81K and bringing the position to 3,137 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.

Advisor Group first reported a position in MGNX in Q2 2016 and has held it in 10 quarters since. The position peaked at $35K in Q2 2019. 124 funds tracked by Wall St. Rank hold MGNX as of Q4 2019.

  • Advisor Group held 3,137 shares of MacroGenics worth $34K as of Q4 2019.
  • Advisor Group bought 688 MacroGenics shares in Q4 2019, an estimated $6.81K.
  • MacroGenics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3664 holding.
  • Advisor Group first reported a position in MacroGenics in Q2 2016 and has held it in 10 quarters since.
  • Advisor Group's MacroGenics position peaked at $35K in Q2 2019.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.